Get started
VALNEVAVALNEVAVALNEVA

VALNEVA

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

4VLA chart


Full chart

4VLA upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪348.18 M‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.044 EUR
Net income (FY)
‪−101.43 M‬ EUR
Revenue (FY)
‪153.71 M‬ EUR
Shares float
‪135.91 M‬
Beta (1Y)
0.84

Employees


Employees (FY)
676
Revenue / Employee (1Y)
‪227.39 K‬ EUR
Net income / Employee (1Y)
‪−150.04 K‬ EUR

About VALNEVA SE


Sector
Health Technology
Industry
Biotechnology
CEO
Thomas Lingelbach
Website
valneva.com
Headquarters
Saint-Herblain
Founded
1999
ISIN
FR0004056851
FIGI
BBG01HQ1X959
Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases addressing unmet medical needs. It currently provides three proprietary travel vaccines: IXIARO, DUKORAL, and IXCHIQ. The IXIARO is an inactivated Vero cell culture-derived Japanese encephalitis vaccine indicated for active immunization against Japanese encephalitis in adults, adolescents, children, and infants aged two months and older. The DUKORAL is a drinkable vaccine that helps prevent diarrhea caused by heat-labile toxin-producing ETEC, as well as cholera. The IXCHIQ is a single-dose, live-attenuated vaccine for the prevention of disease caused by chikungunya virus. The company also offers additional vaccines, including VLA1553, VLA15, VLA160, VLA200, VLA1601 and others. Valneva was founded on May 28, 2013 and is headquartered in Saint-Herblain, France.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

4VLA news



Ideas



See all ideas 

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of 4VLA is 2.102 EUR — it has increased by 12.09% in the past 24 hours. Watch VALNEVA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on EUROTLX exchange VALNEVA stocks are traded under the ticker 4VLA.
4VLA stock has risen by 10.35% compared to the previous week, the month change is a 14.93% rise, over the last year VALNEVA has showed a −55.44% decrease.
We've gathered analysts' opinions on VALNEVA future price: according to them, 4VLA price has a max estimate of 11.00 EUR and a min estimate of 2.85 EUR. Watch 4VLA chart and read a more detailed VALNEVA stock forecast: see what analysts think of VALNEVA and suggest that you do with its stocks.
4VLA reached its all-time high on Dec 1, 2021 with the price of 28.020 EUR, and its all-time low was 1.768 EUR and was reached on Dec 16, 2024. View more price dynamics on 4VLA chart.
See other stocks reaching their highest and lowest prices.
4VLA stock is 1.43% volatile and has beta coefficient of 0.84. Track VALNEVA stock price on the chart and check out the list of the most volatile stocks — is VALNEVA there?
Today VALNEVA has the market capitalization of ‪348.18 M‬, it has increased by 11.76% over the last week.
Yes, you can track VALNEVA financials in yearly and quarterly reports right on TradingView.
VALNEVA is going to release the next earnings report on Mar 20, 2025. Keep track of upcoming events with our Earnings Calendar.
4VLA earnings for the last quarter are −0.05 EUR per share, whereas the estimation was −0.12 EUR resulting in a 58.33% surprise. The estimated earnings for the next quarter are −0.10 EUR per share. See more details about VALNEVA earnings.
VALNEVA revenue for the last quarter amounts to ‪45.80 M‬ EUR, despite the estimated figure of ‪44.95 M‬ EUR. In the next quarter, revenue is expected to reach ‪55.86 M‬ EUR.
4VLA net income for the last quarter is ‪−9.24 M‬ EUR, while the quarter before that showed ‪−24.93 M‬ EUR of net income which accounts for 62.96% change. Track more VALNEVA financial stats to get the full picture.
No, 4VLA doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 31, 2024, the company has 676.00 employees. See our rating of the largest employees — is VALNEVA on this list?
Like other stocks, 4VLA shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade VALNEVA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So VALNEVA technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating VALNEVA stock shows the sell signal. See more of VALNEVA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.